Hedgehog信号通路相关蛋白在人胰腺癌SW1990耐药株中的表达及意义

目的;探讨Hedgehog信号通路蛋白在人胰腺癌吉西他滨耐药细胞株SW1990中的表达,为克服胰腺癌获得性耐药提供实验基础.方法:采用浓度梯度递增法建立人胰腺癌SW1990耐药株,采用噻唑蓝法测定SW1990亲代与耐药细胞IC50.实时荧光定量PCR检测亲代与耐药细胞mRNA中hedgehog信号通路成员Shh 、SMO 、Gli-1的表达差异.Western印迹法检测亲代与耐药细胞中上述蛋白质的表达.结果:人胰腺癌耐药株SW1990的IC50从亲代的(3.1±0.2) μmol/L提高到(232.2±12.3) μmol/L.荧光定量PCR结果显示耐药株中Shh 、Gli-1的表达提高了(12.07±1.71)倍和(4.15±0.42)倍.亲代SW1990中未检测到SMO表达,而耐药细胞中却可以检测到SMO的表达.Western印迹结果同样显示,人胰腺癌SW1990耐药细胞株中高表达上述蛋白质.结论:人胰腺癌耐药株中高表达部分hedgehog信号通路蛋白.针对hedgehog信号通路的靶向治疗可能为克服胰腺癌耐药提供新的理论基础.

Expression and functional significance of hedgehog signal pathway members in drug-resistant SW1990 pancreatic cancer cell line

Objective To investigate the difference of protein expression in hedgehog signal pathway in parental and gemcitabine-resistant pancreatic cancer cell line SW1990.Methods Gemcitabine-resistant cell line SW1990 was established by drug concentration step-elevation method.IC50 to gemcitabine in parental and gemcitabine-resistant cells were determined by MTT.mRNA expression levels of Shh,SMO and Gli-1 were determined by real-time PCR.Protein expression level of Shh,SMO and Gli-1 were determined by Western blot.Results IC50 to gemcitabine was(232.2±12.3) μmol/L in drug-resistant cells and(3.1±0.2) μmol/L in parental cells.mRNA expression of Shh and Gli-1 in gemcitabine-resistant cells increased(12.07±1.71) and(4.15±0.42) fold,respectively,when compared with that in parental cells.mRNA expression of SMO was detectable only in gemcitabine-resistant cells,but not in parental cells.Western blot showed a high expression levels of SMO and Gli-1 proteins in gemcitabine-resistant cells.Conculsions Some members of hedgehog signal pathway are highly expressed in gemcitabine-resistant pancreatic cancer cells.Targeting therapy against hedgehog pathway may contribute to overcome gemcitabine-resistant in pancreatic cancer.